| |
| |
|
| Insider
Information: |
Invus Public Equities Advisors, Llc |
| Relationship: |
10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
32,130,897 |
|
|
Indirect Shares
|
60,240,864 |
|
|
| Direct
Value |
$110,404,108 |
|
|
|
Indirect Value
|
$98,795,017 |
|
|
| Total
Shares |
92,371,761 |
|
|
| Total
Value |
$209,199,125 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
15
|
1
|
|
Stock
price went up :
|
3
|
0
|
| Stock
price went down : |
12
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -11.8%
|
-25.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Lexicon Pharmaceuticals Inc |
LXRX |
Director, 10% Owner |
2014-11-26 |
0 |
2018-06-28 |
60,240,864 |
Premium* |
|
|
Generation Bio Co. |
GBIO |
10% Owner |
2020-06-16 |
2,814,191 |
2020-06-16 |
0 |
Premium* |
|
|
Sqz Biotechnologies Co |
SQZ |
10% Owner |
2020-11-03 |
1,606,308 |
2020-11-03 |
0 |
Premium* |
|
|
Seer, Inc. |
SEER |
10% Owner |
2021-02-01 |
5,588,366 |
2021-02-01 |
0 |
Premium* |
|
|
Omega Therapeutics, Inc. |
OMGA |
10% Owner |
2021-08-03 |
2,273,530 |
2021-07-30 |
0 |
Premium* |
|
|
Scholar Rock Holding Corp |
SRRK |
|
2023-10-12 |
11,259,438 |
|
0 |
Premium* |
|
|
Glycomimetics Inc |
GLYC |
10% Owner |
2023-02-24 |
8,589,064 |
2023-02-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SQZ |
Sqz Biotechnologies Co |
10% Owner |
– – • |
2020-11-03 |
4 |
B |
$16.00 |
$7,440,000 |
D/D |
465,000 |
1,606,308 |
2.45 |
- |
|
| SQZ |
Sqz Biotechnologies Co |
10% Owner |
– – • |
2020-11-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,141,308 |
1,141,308 |
0 |
- |
|
| SEER |
Seer, Inc. |
10% Owner |
– – • |
2021-02-01 |
4 |
S |
$64.15 |
$16,201,519 |
D/D |
(252,545) |
5,588,366 |
0 |
- |
|
| SRRK |
Scholar Rock Holding Corp |
10% Owner |
– – • |
2022-06-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,750,034 |
|
% |
|
| SRRK |
Scholar Rock Holding Corp |
10% Owner |
– – • |
2022-10-03 |
4 |
B |
$7.03 |
$238,789 |
D/D |
33,971 |
8,784,005 |
2.45 |
% |
|
| SRRK |
Scholar Rock Holding Corp |
10% Owner |
– – • |
2022-10-04 |
4 |
B |
$7.89 |
$520,760 |
D/D |
66,000 |
8,850,005 |
2.45 |
% |
|
| SRRK |
Scholar Rock Holding Corp |
10% Owner |
– – • |
2022-10-25 |
4 |
B |
$8.04 |
$1,047,383 |
D/D |
130,265 |
8,980,270 |
2.45 |
% |
|
| SRRK |
Scholar Rock Holding Corp |
10% Owner |
– – • |
2023-01-05 |
4 |
B |
$9.33 |
$455,091 |
D/D |
48,774 |
9,029,044 |
2.45 |
% |
|
| SRRK |
Scholar Rock Holding Corp |
10% Owner |
– – • |
2023-01-09 |
4 |
S |
$9.48 |
$10,373 |
D/D |
(1,094) |
9,027,950 |
0 |
% |
|
| SRRK |
Scholar Rock Holding Corp |
10% Owner |
– – • |
2023-04-28 |
4 |
B |
$6.43 |
$202,845 |
D/D |
31,557 |
9,059,507 |
2.45 |
% |
|
| SRRK |
Scholar Rock Holding Corp |
|
– – • |
2023-10-12 |
4 |
B |
$6.85 |
$15,086,736 |
D/D |
2,199,931 |
11,259,438 |
0.01 |
% |
|
| OMGA |
Omega Therapeutics, Inc. |
10% Owner |
– – • |
2021-07-30 |
4 |
B |
$16.14 |
$1,210,343 |
D/D |
75,000 |
75,000 |
2.45 |
- |
|
| OMGA |
Omega Therapeutics, Inc. |
10% Owner |
– – • |
2021-08-03 |
4 |
B |
$17.00 |
$14,875,000 |
D/D |
875,000 |
2,273,530 |
2.45 |
% |
|
| OMGA |
Omega Therapeutics, Inc. |
10% Owner |
– – • |
2021-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,323,530 |
1,398,530 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
– • • |
2014-11-26 |
4 |
B |
$1.01 |
$150,000,000 |
I/I |
149,253,731 |
149,253,731 |
2.25 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
– • • |
2017-11-10 |
4 |
AB |
$9.74 |
$1,418,384 |
I/I |
145,680 |
939,007 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
– • • |
2017-11-13 |
4 |
AB |
$9.75 |
$2,097,934 |
I/I |
215,133 |
1,154,140 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
– • • |
2017-11-14 |
4 |
AB |
$9.47 |
$2,037,847 |
I/I |
215,133 |
1,369,273 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
– • • |
2017-11-15 |
4 |
AB |
$10.21 |
$1,334,396 |
I/I |
130,727 |
1,500,000 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
– • • |
2017-11-17 |
4 |
AB |
$9.85 |
$492,500 |
I/I |
50,000 |
1,550,000 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
– • • |
2018-05-25 |
4 |
AB |
$9.62 |
$1,334,974 |
I/I |
138,700 |
1,688,700 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
– • • |
2018-05-29 |
4 |
AB |
$9.84 |
$1,450,420 |
I/I |
147,339 |
1,836,039 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
– • • |
2018-05-30 |
4 |
AB |
$10.32 |
$1,521,025 |
I/I |
147,339 |
1,983,378 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
– • • |
2018-05-31 |
4 |
AB |
$11.62 |
$1,712,050 |
I/I |
147,339 |
2,130,717 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Director |
– • • |
2018-06-01 |
4 |
AB |
$12.22 |
$1,800,041 |
I/I |
147,339 |
2,278,056 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
